Annual Total Debt
$5.79 B
-$20.50 M-0.35%
31 December 2023
Summary:
Jazz Pharmaceuticals annual total debt is currently $5.79 billion, with the most recent change of -$20.50 million (-0.35%) on 31 December 2023. During the last 3 years, it has fallen by -$361.29 million (-5.87%). JAZZ annual total debt is now -5.87% below its all-time high of $6.15 billion, reached on 31 December 2021.JAZZ Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$6.20 B
+$410.48 M+7.09%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly total debt is currently $6.20 billion, with the most recent change of +$410.48 million (+7.09%) on 30 September 2024. Over the past year, it has increased by +$410.41 million (+7.09%). JAZZ quarterly total debt is now -10.31% below its all-time high of $6.92 billion, reached on 30 June 2021.JAZZ Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +7.1% |
| 3 y3 years | -5.9% | +0.8% |
| 5 y5 years | +227.0% | +250.2% |
JAZZ Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | at low | at high | +7.2% |
| 5 y | 5 years | -5.9% | +227.0% | -10.3% | +250.4% |
| alltime | all time | -5.9% | -10.3% |
Jazz Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.20 B(+7.1%) |
| June 2024 | - | $5.79 B(+0.1%) |
| Mar 2024 | - | $5.79 B(-0.1%) |
| Dec 2023 | $5.79 B(-0.4%) | $5.79 B(-0.0%) |
| Sept 2023 | - | $5.79 B(-0.1%) |
| June 2023 | - | $5.80 B(-0.2%) |
| Mar 2023 | - | $5.81 B(-0.0%) |
| Dec 2022 | $5.81 B(-5.5%) | $5.81 B(-0.0%) |
| Sept 2022 | - | $5.81 B(-4.9%) |
| June 2022 | - | $6.11 B(-0.1%) |
| Mar 2022 | - | $6.12 B(-0.5%) |
| Dec 2021 | $6.15 B(+173.5%) | $6.15 B(-3.6%) |
| Sept 2021 | - | $6.38 B(-7.7%) |
| June 2021 | - | $6.92 B(+207.1%) |
| Mar 2021 | - | $2.25 B(+0.1%) |
| Dec 2020 | $2.25 B(+27.0%) | $2.25 B(+0.3%) |
| Sept 2020 | - | $2.24 B(-0.8%) |
| June 2020 | - | $2.26 B(+27.7%) |
| Mar 2020 | - | $1.77 B(-0.1%) |
| Dec 2019 | $1.77 B(+10.9%) | $1.77 B(+0.1%) |
| Sept 2019 | - | $1.77 B(+0.2%) |
| June 2019 | - | $1.77 B(+0.3%) |
| Mar 2019 | - | $1.76 B(+10.3%) |
| Dec 2018 | $1.60 B(+1.0%) | $1.60 B(+0.2%) |
| Sept 2018 | - | $1.59 B(+0.1%) |
| June 2018 | - | $1.59 B(+0.6%) |
| Mar 2018 | - | $1.58 B(+0.1%) |
| Dec 2017 | $1.58 B(-22.1%) | $1.58 B(+0.1%) |
| Sept 2017 | - | $1.58 B(-5.5%) |
| June 2017 | - | $1.67 B(-10.9%) |
| Mar 2017 | - | $1.88 B(-7.6%) |
| Dec 2016 | $2.03 B(+70.8%) | $2.03 B(-7.0%) |
| Sept 2016 | - | $2.18 B(+85.2%) |
| June 2016 | - | $1.18 B(-0.4%) |
| Mar 2016 | - | $1.18 B(-0.4%) |
| Dec 2015 | $1.19 B(-11.5%) | $1.19 B(-7.9%) |
| Sept 2015 | - | $1.29 B(-5.6%) |
| June 2015 | - | $1.37 B(+1.7%) |
| Mar 2015 | - | $1.34 B(+0.1%) |
| Dec 2014 | $1.34 B | $1.34 B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $1.34 B(+12.1%) |
| June 2014 | - | $1.20 B(-0.2%) |
| Mar 2014 | - | $1.20 B(+117.9%) |
| Dec 2013 | $549.98 M(+20.4%) | $549.98 M(-0.2%) |
| Sept 2013 | - | $551.14 M(-0.2%) |
| June 2013 | - | $552.30 M(+22.4%) |
| Mar 2013 | - | $451.16 M(-1.2%) |
| Dec 2012 | $456.76 M(>+9900.0%) | $456.76 M(-1.2%) |
| Sept 2012 | - | $462.35 M(-1.2%) |
| June 2012 | - | $467.94 M(>+9900.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) |
| June 2011 | - | $36.69 M(-9.8%) |
| Mar 2011 | - | $40.70 M(-15.3%) |
| Dec 2010 | $48.04 M(-61.3%) | $48.04 M(>+9900.0%) |
| Sept 2010 | - | $0.00(-100.0%) |
| June 2010 | - | $48.62 M(-59.7%) |
| Mar 2010 | - | $120.55 M(-3.0%) |
| Dec 2009 | $124.27 M(+1.5%) | $124.27 M(+5.0%) |
| Sept 2009 | - | $118.36 M(-8.6%) |
| June 2009 | - | $129.48 M(-3.8%) |
| Mar 2009 | - | $134.63 M(+10.0%) |
| Dec 2008 | $122.41 M(+55.8%) | $122.41 M(+4.7%) |
| Sept 2008 | - | $116.88 M(-2.4%) |
| June 2008 | - | $119.80 M(+2.8%) |
| Mar 2008 | - | $116.55 M(+48.3%) |
| Dec 2007 | $78.58 M(+2.7%) | $78.58 M(+1.4%) |
| Sept 2007 | - | $77.46 M(-0.4%) |
| June 2007 | - | $77.76 M(+0.3%) |
| Mar 2007 | - | $77.53 M(+1.4%) |
| Dec 2006 | $76.47 M(+3.9%) | $76.47 M(>+9900.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(-100.0%) |
| Dec 2005 | $73.63 M(>+9900.0%) | $73.63 M(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00 |
| Dec 2004 | $0.00 | - |
FAQ
- What is Jazz Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total debt year-on-year change?
What is Jazz Pharmaceuticals annual total debt?
The current annual total debt of JAZZ is $5.79 B
What is the all time high annual total debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total debt is $6.15 B
What is Jazz Pharmaceuticals quarterly total debt?
The current quarterly total debt of JAZZ is $6.20 B
What is the all time high quarterly total debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total debt is $6.92 B
What is Jazz Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, JAZZ quarterly total debt has changed by +$410.41 M (+7.09%)